Highlights and Quick Summary
- Other current liabilities for the quarter ending September 30, 2023 was $2.23 Million (a -72.71% decrease compared to previous quarter)
- Year-over-year quarterly Other current liabilities decreased by -79.98%
- Annual Other current liabilities for 2022 was $11.2 Million (a -14.13% decrease from previous year)
- Annual Other current liabilities for 2021 was $13 Million (a 166.4% increase from previous year)
- Annual Other current liabilities for 2020 was $4.88 Million (a 225.65% increase from previous year)
Visit stockrow.com/ARAV
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Other current liabilities of ARAVIVE, INC
Most recent Other current liabilitiesof ARAV including historical data for past 10 years.Interactive Chart of Other current liabilities of ARAVIVE, INC
ARAVIVE, INC Other current liabilities for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $2.23 | $8.18 | $8.23 | – | – |
| 2022 | $11.15 | $12.69 | $14.53 | $13.26 | $11.15 |
| 2021 | $12.99 | $9.88 | $5.63 | $3.76 | $12.99 |
| 2020 | $4.88 | $1.47 | $1.38 | $1.45 | $4.88 |
| 2019 | – | – | – | $1.5 | $1.5 |
| 2018 | – | – | – | – | $1.51 |
| 2017 | – | $40.0 | $40.0 | $40.0 | $4.09 |
| 2016 | $40.0 | $40.0 | – | – | $40.0 |
Business Profile of ARAVIVE, INC
Sector: Healthcare
Industry: Biotechnology